Decheng Capital Management III »

Roivant Sciences Ltd Shs Isin #bmg762791017 shares owned by Decheng Capital Management III

Quarter-by-quarter ownership of Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV) shares owned by Decheng Capital Management III from 13F filings

Historical chart of Decheng Capital Management III investment in Roivant Sciences Ltd Shs Isin #bmg762791017

Tip: Access up to 7 years of quarterly data

All positions including Roivant Sciences Ltd Shs Isin #bmg762791017 held by Decheng Capital Management III consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Roivant Sciences Ltd Shs Isin #bmg762791017 by Decheng Capital Management III

Quarter filed Position value Share count Share price at filing
2023-09-30 $17M 1.5M 11.68

More positions owned by Decheng Capital Management III

Alpine Immune Sciences
Zentalis Pharmaceuticals (ZNTL)
Aura Biosciences (AURA)
Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV)
Acelyrin (SLRN)
Arcus Biosciences Incorporated (RCUS)
10x Genomics Cl A Com (TXG)
Argenx SE SHS (ARGX)
Pacific Biosciences of California (PACB)
Illumina (ILMN)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Horizon Therapeutics
Phathom Pharmaceuticals (PHAT)
ImmunoGen
Seagen

View all positions for Decheng Capital Management III

Top funds holding Roivant Sciences Ltd Shs Isin #bmg762791017

QVT Financial
Viking Global Investors
BlackRock
BlackRock
Morgan Stanley
Rubric Capital Management
State Street Corporation
Patient Square Capital
Two Seas Capital
Woodline Partners
Vanguard Group
Geode Capital Management
Invesco
Citadel Advisors
DME Capital Management

View all funds holding Roivant Sciences Ltd Shs Isin #bmg762791017